Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 12:46 PM View:  | Hemispherx Biopharma, Inc. (AIM) | 20-Nov-24 | Private Purchase | 60,110 | $0.18 | $11,000.10 | 4% 1.49M to 1.55M | |
| Yesterday 12:04 PM View: | Hemispherx Biopharma, Inc. (AIM) | 20-Nov-24 | Private Purchase | 85,000 | $0.20 | $16,915.00 | 5% 1.55M to 1.64M | |
| 17-Sep-24 12:05 PM View: | Hemispherx Biopharma, Inc. (AIM) | 16-Sep-24 | Private Purchase | 5,000 | $0.30 | $1,515.00 | < 1% 1.49M to 1.49M | |
| 16-Sep-24 3:45 PM View: | Hemispherx Biopharma, Inc. (AIM) | 13-Sep-24 | Private Purchase | 20,000 | $0.31 | $6,160.00 | 1% 1.47M to 1.49M | |
| 12-Sep-24 5:15 PM View: | Hemispherx Biopharma, Inc. (AIM) | 11-Sep-24 | Grant | 312,500 | $0.32 | $100,000.00 | 27% 1.16M to 1.47M | |
| 07-May-24 8:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 06-May-24 | Private Purchase | 61,729 | $0.41 | $25,000.20 | 9% 716.46K to 778.18K | |
| 18-Mar-24 3:01 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 75,758 | $0.33 | $25,000.10 | 12% 640.7K to 716.46K | |
| 27-Nov-23 12:56 PM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Nov-23 | Private Purchase | 33,861 | $0.44 | $15,000.40 | 6% 606.84K to 640.7K | |
| 29-Sep-23 3:29 PM View: | Hemispherx Biopharma, Inc. (AIM) | 29-Sep-23 | Private Purchase | 22,676 | $0.44 | $10,000.10 | 4% 584.16K to 606.84K | |
| 25-Aug-23 2:26 PM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Aug-23 | Private Purchase | 8,222 | $0.67 | $5,500.52 | 1% 575.94K to 584.16K | |
| 24-Aug-23 1:52 PM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Aug-23 | Private Purchase | 14,993 | $0.67 | $10,000.30 | 3% 560.95K to 575.94K | |
| 17-Jul-23 7:20 PM View: | Hemispherx Biopharma, Inc. (AIM) | 17-Jul-23 | Private Purchase | 16,950 | $0.59 | $10,000.50 | 3% 544.0K to 560.95K | |
| 04-Jan-23 7:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 161,291 | $0.31 | $50,000.20 | 42% 382.7K to 544.0K | |
| 18-Jul-22 3:01 PM View: | Hemispherx Biopharma, Inc. (AIM) | 18-Jul-22 | Grant | 32,895 | $0.76 | $25,000.20 | 9% 349.81K to 382.7K | |
| 26-Apr-22 8:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 49,020 | $1.02 | $50,000.40 | 16% 300.79K to 349.81K | (11%) |
| 13-Dec-21 11:26 AM View: | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-21 | Grant | 21,552 | $1.16 | $25,000.30 | 8% 279.24K to 300.79K | (3%) |
| 10-Dec-21 10:55 AM View: | Hemispherx Biopharma, Inc. (AIM) | 10-Dec-21 | Grant | 11,811 | $1.27 | $15,000.00 | 4% 267.43K to 279.24K | (9%) |
| 24-Nov-21 1:51 PM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Nov-21 | Grant | 11,627 | $1.29 | $14,998.80 | 5% 255.8K to 267.43K | 0% |
| 23-Nov-21 11:08 AM View: | Hemispherx Biopharma, Inc. (AIM) | 23-Nov-21 | Grant | 11,194 | $1.34 | $15,000.00 | 5% 244.6K to 255.8K | (11%) |
| 19-Nov-21 11:28 AM View: | Hemispherx Biopharma, Inc. (AIM) | 19-Nov-21 | Grant | 10,204 | $1.47 | $14,999.90 | 4% 234.4K to 244.6K | (21%) |
| 17-Nov-21 5:27 PM View: | Hemispherx Biopharma, Inc. (AIM) | 17-Nov-21 | Grant | 9,146 | $1.64 | $14,999.40 | 4% 225.25K to 234.4K | (27%) |
| 16-Jul-21 12:07 PM View: | Hemispherx Biopharma, Inc. (AIM) | 16-Jul-21 | Market Purchase | 15,625 | $1.92 | $30,000.00 | 7% 209.63K to 225.25K | (38%) |
| 24-Feb-21 12:03 PM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Feb-21 | Market Purchase | 11,062 | $2.26 | $25,000.10 | 6% 198.57K to 209.63K | (48%) |
| 17-Dec-20 12:22 PM View: | Hemispherx Biopharma, Inc. (AIM) | 17-Dec-20 | Market Purchase | 14,535 | $1.72 | $25,000.20 | 8% 184.03K to 198.57K | (31%) |
| 03-Sep-20 10:53 AM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Sep-20 | Market Purchase | 12,316 | $2.03 | $25,001.50 | 7% 171.72K to 184.03K | (43%) |
| 21-Aug-20 8:08 AM View: | Hemispherx Biopharma, Inc. (AIM) | 21-Aug-20 | Market Purchase | 10,730 | $2.33 | $25,000.90 | 7% 160.99K to 171.72K | (51%) |
| 02-Jan-20 10:47 AM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Dec-19 | Grant | 14,741 | $0.53 | $7,812.73 | 10% 146.25K to 160.99K | 104% |
| 16-Dec-19 9:25 AM View: | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Grant | 17,960 | $0.44 | $7,812.60 | 14% 128.29K to 146.25K | 148% |
| 02-Dec-19 11:48 AM View: | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Grant | 19,531 | $0.40 | $7,812.40 | 18% 108.76K to 128.29K | 200% |
| 18-Nov-19 2:30 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Grant | 16,622 | $0.47 | $7,812.34 | 18% 92.14K to 108.76K | 194% |
| 31-Oct-19 11:36 AM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Oct-19 | Grant | 15,625 | $0.50 | $7,812.50 | 20% 76.51K to 92.14K | 140% |
| 17-Oct-19 4:32 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Oct-19 | Grant | 13,470 | $0.58 | $7,812.60 | 21% 63.04K to 76.51K | 128% |
| 27-Jun-19 3:32 PM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Jun-19 | Market Purchase | 2,632 | $4.37 | $11,501.80 | 4% 60.41K to 63.04K | (73%) |
| 21-Jun-19 11:11 AM View: | Hemispherx Biopharma, Inc. (AIM) | 21-Jun-19 | Market Purchase | 29,404 | $4.03 | $118,498.00 | 2% 1.36M to 1.39M | (71%) |
| 17-Jun-19 1:23 PM View: | Hemispherx Biopharma, Inc. (AIM) | 08-May-19 | Conversion | 227,500 | -- | -- | 20% 1.14M to 1.36M | |
| 19-Mar-19 4:01 PM View: | Hemispherx Biopharma, Inc. (AIM) | 19-Mar-19 | Market Purchase | 13,400 | $0.18 | $2,351.70 | 2% 798.31K to 811.71K | (88%) |
| 17-Jun-19 1:23 PM View: | Hemispherx Biopharma, Inc. (AIM) | 18-Mar-19 | Conversion | 325,000 | -- | -- | 40% 811.71K to 1.14M | |
| 12-Mar-19 4:29 PM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Feb-19 | Exercise (in-the money or at-the-money) | 325,065 | -- | -- | 100% 0 to 325.06K | |
| 03-Dec-18 11:32 AM View: | Hemispherx Biopharma, Inc. (AIM) | 30-Nov-18 | Market Purchase | 20,000 | $0.19 | $3,844.99 | 3% 778.31K to 798.31K | (90%) |
| 29-Nov-18 10:34 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Nov-18 | Grant | 2,500 | -- | -- | < 1% 775.81K to 778.31K | |
| 29-Oct-18 9:14 AM View: | Hemispherx Biopharma, Inc. (AIM) | 26-Oct-18 | Market Purchase | 3,500 | $0.20 | $710.50 | < 1% 772.31K to 775.81K | (89%) |
| 25-Oct-18 9:22 AM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Oct-18 | Market Purchase | 100,000 | $0.20 | $20,000.00 | 15% 672.31K to 772.31K | (89%) |
| 27-Jul-18 9:31 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Jul-18 | Market Purchase | 34,483 | $0.29 | $10,000.10 | 5% 637.82K to 672.31K | (91%) |
| 23-Jul-18 10:49 AM View: | Hemispherx Biopharma, Inc. (AIM) | 23-Jul-18 | Market Purchase | 112,904 | $0.31 | $35,000.20 | 22% 524.92K to 637.82K | (92%) |
| 30-Apr-18 6:22 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Apr-18 | Market Purchase | 32,000 | $0.32 | $10,240.00 | 6% 492.92K to 524.92K | (91%) |
| 27-Apr-17 9:27 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Apr-17 | Market Purchase | 72,464 | $0.69 | $50,000.20 | 17% 420.45K to 492.92K | (96%) |
| 11-Apr-17 9:54 AM View: | Hemispherx Biopharma, Inc. (AIM) | 11-Apr-17 | Market Purchase | 200,000 | $0.50 | $100,000.00 | 91% 220.46K to 420.45K | (94%) |
| 23-Dec-16 12:31 PM View: | Hemispherx Biopharma, Inc. (AIM) | 22-Dec-16 | Market Purchase | 68,493 | $0.73 | $49,999.90 | 45% 151.96K to 220.46K | (96%) |
| 01-Nov-16 1:27 PM View: | Hemispherx Biopharma, Inc. (AIM) | 01-Nov-16 | Market Purchase | 10,000 | $1.00 | $10,000.00 | 7% 141.96K to 151.96K | (97%) |
| 08-Jul-16 5:10 PM View: | Hemispherx Biopharma, Inc. (AIM) | 08-Jul-16 | Market Purchase | 48,000 | $0.12 | $5,683.20 | 3% 1.66M to 1.7M | (98%) |